Induction of antioxidative Nrf2 gene transcription by coffee in humans: depending on genotype?
The Nrf2/ARE pathway is a major cellular defense mechanism that prevents damage by reactive oxygen species through induction of antioxidative phase II enzymes. However, the activity of the Nrf2/ARE system is not uniform with variability in response presumed to be dependent on the Nrf2 genotype. We recently completed a pilot human coffee intervention trial with healthy humans, where large interindividual differences in the antioxidative response to the study coffee were examined. Here, we address the question whether differences in the modulation of Nrf2 gene transcription, assessed as an induction of Nrf2 gene transcription by Q-PCR, might be correlated with specific Nrf2 genotypes. To date, nine single nucleotide polymorphisms (SNPs) have been identified in the Nrf2 (NFE2L2) gene. Two of these, the -617C/A and -651G/A SNPs are located within the promoter region and have previously been reported to influence the activity of the Nrf2/ARE pathway by reducing Nrf2 transcriptional activity. Sequencing of the critical Nrf2 gene promoter region not only confirmed the existence of these SNPs within the participants of the trial at the expected frequency (33% carrying the -617C/A, 17% the -651G/A and 56% the -653A/G SNP) but also indicated reduced Nrf2 gene transcription associated with a normal diet if the SNPs at position -617, -651 or -653 were present. Of note, the data also indicated the study coffee increased Nrf2 gene transcription even in SNP carriers. This further highlights the relevance of genotype-dependent induction of Nrf2 gene transcription that appears to be largely influenced by dietary factors.
Department of Food Chemistry and Toxicology, Institut für Lebensmittelchemie und Toxikologie, University of Vienna, Vienna (Wien), Austria. ute.boettler@univie.ac.at
Ute
U
Boettler
Nadine
N
Volz
Nicole
N
Teller
Larisa M
LM
Haupt
Tamara
T
Bakuradze
Gerhard
G
Eisenbrand
Gerhard
G
Bytof
Ingo
I
Lantz
Lyn R
LR
Griffiths
Doris
D
Marko
D000975:Antioxidants / Q000378:metabolism; D001483:Base Sequence; D002110:Caffeine / Q000494:pharmacology; D003069:Coffee; D004249:DNA Damage; D005787:Gene Frequency; D056726:Genetic Association Studies; D005838:Genotype; D005978:Glutathione / Q000097:blood; D006801:Humans; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism; D008297:Male; D051267:NF-E2-Related Factor 2 / Q000235:genetics* / Q000378:metabolism; D020641:Polymorphism, Single Nucleotide; D017422:Sequence Analysis, DNA; D014158:Transcription, Genetic / Q000187:drug effects*; D015533:Transcriptional Activation / Q000187:drug effects*
D000975:Antioxidants; D003069:Coffee; D051267:NF-E2-Related Factor 2; C495635:NFE2L2 protein, human; D002110:Caffeine; D005978:Glutathione